3-'4-heterocyclyl-1,2,3,-triazol-1-yl!-n-aryl-benzamides as...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 403/04 (2006.01) A61K 31/4178 (2006.01) A61K 31/4192 (2006.01) A61K 31/4439 (2006.01) A61P 35/00 (2006.01) C07D 401/04 (2006.01) C07D 401/14 (2006.01) C07D 405/04 (2006.01) C07D 413/04 (2006.01) C07D 417/04 (2006.01)

Patent

CA 2557856

Disclosed compounds of formula (I), which inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds.

La présente invention a trait à des composés de formule (I), inhibiteurs de la production de cytokines impliquées dans des processus inflammatoires et sont donc utiles pour le traitement de maladies et de conditions pathologiques entraînant l'inflammation telles que la maladie inflammatoire chronique. L'invention a également trait à des procédés pour la préparation de tels composés et à des compositions pharmaceutiques comportant ces composés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

3-'4-heterocyclyl-1,2,3,-triazol-1-yl!-n-aryl-benzamides as... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-'4-heterocyclyl-1,2,3,-triazol-1-yl!-n-aryl-benzamides as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-'4-heterocyclyl-1,2,3,-triazol-1-yl!-n-aryl-benzamides as... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1517886

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.